Adjuvant Immunotherapy of Melanoma: The Current Status and Outlook for the Next Few Years

In this MEDtalk, Marco Donia, Professor, MD, PhD in immuno-oncology at the University of Copenhagen, presents the current status of adjuvant immunotherapy for the treatment of malignant melanoma. The presentation is based on a scientific article published this year in ESMO Open, authored by a group of melanoma experts from Europe.